Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma

Cancer Science

Volumn 102, Issue 3, 2011, Pages 583-590

  Dai, Chun ^a,b   Dong, Qiong Zhu ^a,b   Ren, Ning ^a,b   Zhu, Jun Jie ^a,b   Zhou, Hai Jun ^a,b   Sun, Hai Jing ^a,b   Wang, Guan ^a,b   Zhang, Xiao Fei ^a,b   Xue, Yu Hua ^a,b   Jia, Hu Liang ^a,b   Ye, Qing Hai ^a,b   Qin, Lun Xiu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACID PHOSPHATASE TYPE 2 DOMAIN CONTAINING 1B, TRANSCRIPT VARIANT 1; PHOSPHATIDIC ACID PHOSPHATASE TYPE 2 DOMAIN CONTAINING 1B, TRANSCRIPT VARIANT 2; PHOSPHATIDIC ACID PHOSPHATASE TYPE 2 DOMAIN CONTAINING 1B, TRANSCRIPT VARIANT 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR THROMBUS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 8; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHATIDATE PHOSPHATASE; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 79951684904     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01863.x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Tang ZY, Ye SL, Liu YK et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 187-96.
3. Sherman M. Recurrence of Hepatocellular Carcinoma. N Engl J Med 2008; 359: 2045-7.
4. Bruix J, Llovet JM. Major achievements in hepato cellular carcinoma. Lancet 2009; 373: 614-6.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
6. Wu X, Jia HL, Wang YF et al. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma. Oncogene 2006; 25: 1832-40.
7. Bernard-Pierrot I, Gruel N, Stransky N et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 2008; 68: 7165-75.
8. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003; 3: 55-63.
9. Ye QH, Qin LX, Forgues M et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416-23.
10. Budhu A, Forgues M, Ye QH et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006; 10: 99-111.
11. Qin LX, Tang XY, Sham JST et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 1999; 59: 5662-5.
12. Khan J, Wei JS, Ringner M et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001; 7: 673-9.
13. Budhu A, Jia HL, Forgues M et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008; 47: 897-907.
14. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002; 30: 503-12.
15. Schmitten TD, Livak KJ. Analyzing real-time PCR data by the comparative C method. Nat Protoc 2008; 3: 1101-8.
16. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94: 2511-6.
17. Fu LY, Jia HL, Dong QZ et al. Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer 2009; 9: 49.
18. Li Y, Tian B, Yang J et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 2004; 130: 460-8.
19. Tian J, Tang ZY, Ye SL et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 1999; 81: 814-21.
20. Llovet JM, Di Bisceglie AM, Bruix J et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711.
21. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-95.
22. Smith SC, Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer 2009; 9: 253-64.
23. Qin LX, Tang ZY, Ye SL et al. Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared. J Cancer Res Clin Oncol 2001; 127: 482-8.
24. Fidler IL. Timeline - The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
25. Chambers AF. The metastatic process: basic research and clinical implications. Oncol Res 1999; 11: 161-8.
26. Tsai TJ, Chau GY, Lui WY et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-8.
27. Ikai I, Yamaoka Y, Yamamoto Y et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis - Proposal as a standard therapy. Ann Surg 1998; 227: 433-9.
28. Gopalakrishnan S, Emburgh BO, Shan JX et al. A novel DNMT3B splice variant expressed in tumor and pluripotent cells modultes genomic DNA methylation patterns and displays altered DNA bind. Mol Cancer Res 2009; 7: 1622-34.
29. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336.
30. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 2001; 17: 509-19.
31. Szallasi Z. Genetic network analysis in light of massively parallel biological data acquisition. Pac Symp Biocomput 1999; 4: 5-16.
32. Dov G, Christopher C, Kenneth W et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003; 4: 117.